2013 Deep Research Report on China Human Use Rabies Vaccine Industry

DUBLIN, November 13, 2013 /PRNewswire/ --

Research and Markets ( http://www.researchandmarkets.com/research/tmp22h/2013_deep) has announced the addition of the "2013 Deep Research Report on China Human Use Rabies Vaccine Industry" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

This 2013 Deep Research Report is a professional and in-depth research report on the Chinese Human Use Rabies Vaccine industry. In the beginning the report describes the definition, classification, industry chain and other related information of the industry. It then discusses manufacturing technology and product specifications.

This report gives summary statistics on Chinas major Rabies Vaccine manufacturers giving details on capacity, production, supply, demand, shortage, selling price, cost, gross margin, production value and Chinese market share.

In the end, this report discusses the 4 Million Boxes/year Human Use Rabies Vaccine project feasibility analysis and investment return analysis and gives related research conclusions and development trend analysis of the industry.

Key Topics Covered:

Chapter One Human Use Rabie Vaccine (Hamster Kidney Cell) Industry Overview

Chapter Two Human Use Rabie Vaccine (Vero Cell) Industry Overview

Chapter Three Human Use Rabie Vaccine (Chicken Embryo Cell) Industry Overview

Chapter Four Human Use Rabie Vaccine Industry Chain Analysis

Chapter Five Human Use Rabie Vaccine Production Supply Sales Demand Market Status and Forecast

Chapter Six Human Use Rabie Vaccine Key Manufacturer Analysis

Chapter Seven Human Use Rabie Vaccine New Project Investment Feasibility Analysis

Chapter Eight Human Use Rabie Vaccine Industry Research Conclusions


Companies Mentioned

- Yatai Group
- Dalian Hissen
- Langzhou Institute of Biological Products
- Henan Puxin Biological Engineering (2011 Sold To Yatai Group)
- ForwellBoipharm (2010 Stop)
- ChengdaBoitechnology
- Liaoning Yisheng
- Promise Biological
- BCHT Pharm (Jilin Maifeng)
- Changchun Changsheng
- Zhejiang Vacinbio-pharmaceutical
- Wuhan Institute of Biological Products (2011 Stop)
- Jiangsu Yansheng Biological (2010 Stop)
- Dalian JingangAndi Biological (2009 Stop)
- Sanofipasteur
- Chiron Behring

For more information visit http://www.researchandmarkets.com/research/tmp22h/2013_deep

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals